Mueller Brian has filed 39 insider transactions across 1 company since January 2023.
Most recent transaction: a tax payment of 2117 shares of BIOMARIN PHARMACEUTICAL INC ($BMRN) on March 17, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 2117 | $56.05 | 123,314.0000 | 196,893,000 | 1.69% | 0.00% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 18740 | $0.00 | 125,431.0000 | 196,893,000 | 17.56% | 0.01% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Stock Option (Right to Buy Common Stock) | 44600 | $0.00 | 44,600.0000 | 196,893,000 | 9999.99% | 0.02% |
| March 13, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 9945 | $58.51 | 106,691.0000 | 196,893,000 | 8.53% | 0.01% |
| Feb. 25, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 2569 | $0.00 | 116,638.0000 | 196,893,000 | 2.25% | 0.00% |
| Feb. 25, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 6683 | $0.00 | 106,839.0000 | 196,893,000 | 6.67% | 0.00% |
| Feb. 25, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 7230 | $0.00 | 114,069.0000 | 196,893,000 | 6.77% | 0.00% |
| April 30, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 375 | $54.14 | 100,156.0000 | 196,708,000 | 0.38% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 16640 | $0.00 | 99,781.0000 | 196,708,000 | 20.01% | 0.01% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Stock Option (Right to Buy Common Stock) | 38590 | $0.00 | 38,590.0000 | 196,708,000 | 9999.99% | 0.02% |
| March 14, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 18497 | $69.44 | 83,141.0000 | 196,708,000 | 18.20% | 0.01% |
| Feb. 25, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 9660 | $0.00 | 92,271.0000 | 196,708,000 | 11.69% | 0.00% |
| Feb. 25, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 9367 | $0.00 | 101,638.0000 | 196,708,000 | 10.15% | 0.00% |
| Feb. 25, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 11040 | $0.00 | 82,611.0000 | 196,708,000 | 15.43% | 0.01% |
| June 28, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 588 | $82.33 | 71,571.0000 | 191,595,000 | 0.81% | 0.00% |
| April 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 300 | $68.65 | 72,159.0000 | 191,595,000 | 0.42% | 0.00% |
| May 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | M | Common Stock | 5000 | $63.10 | 77,159.0000 | 191,595,000 | 6.93% | 0.00% |
| May 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | S | Common Stock | 5000 | $75.19 | 72,159.0000 | 191,595,000 | 6.48% | 0.00% |
| May 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | M | Stock Option (Right to Buy Common Stock) | 5000 | $0.00 | 0.0000 | 191,595,000 | 100.00% | 0.00% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 11400 | $0.00 | 92,648.0000 | 191,595,000 | 14.03% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 20789 | $83.87 | 71,859.0000 | 191,595,000 | 22.44% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Stock Option (Right to Buy Common Stock) | 25540 | $0.00 | 25,540.0000 | 191,595,000 | 9999.99% | 0.01% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 8802 | $0.00 | 75,145.0000 | 191,595,000 | 13.27% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 6103 | $0.00 | 81,248.0000 | 191,595,000 | 8.12% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 20220 | $0.00 | 66,343.0000 | 191,595,000 | 43.84% | 0.01% |
| April 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 318 | $66.88 | 46,123.0000 | 188,963,000 | 0.69% | 0.00% |
| June 29, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 4602 | $88.93 | 50,983.0000 | 188,963,000 | 8.28% | 0.00% |
| June 29, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 4602 | $88.93 | 46,381.0000 | 188,963,000 | 9.03% | 0.00% |
| June 29, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 576 | $88.93 | 45,805.0000 | 188,963,000 | 1.24% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 2708 | $87.74 | 59,558.0000 | 188,963,000 | 4.35% | 0.00% |
| March 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | F | Common Stock | 3973 | $93.41 | 55,585.0000 | 188,963,000 | 6.67% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Stock Option (Right to buy Common Stock) | 21970 | $0.00 | 21,970.0000 | 188,963,000 | 9999.99% | 0.01% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 9630 | $0.00 | 62,266.0000 | 188,963,000 | 18.30% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 12660 | $0.00 | 40,406.0000 | 188,963,000 | 45.63% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 10980 | $0.00 | 51,386.0000 | 188,963,000 | 27.17% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | A | Common Stock | 1250 | $0.00 | 52,636.0000 | 188,963,000 | 2.43% | 0.00% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | M | Stock Option (Right to buy Common Stock) | 2500 | $0.00 | 5,000.0000 | 188,963,000 | 33.33% | 0.00% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | S | Common Stock | 2500 | $114.50 | 27,746.0000 | 188,963,000 | 8.27% | 0.00% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Mueller Brian | EVP, Chief Financial Officer | M | Common Stock | 2500 | $63.10 | 30,246.0000 | 188,963,000 | 9.01% | 0.00% |